Whitehawk Therapeutics (WHWK) Other Non-Current Assets (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 11 years of Other Non-Current Assets data on file, last reported at $1.7 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 23.33% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 23.33% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 29.66% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.7 million, down from $1.8 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for WHWK reached as high as $2.3 million in Q1 2022 and fell as low as $1.4 million in Q1 2025.
• Historically, Other Non-Current Assets has averaged $1.9 million across 5 years, with a median of $1.9 million in 2023.
• Across the five-year window, Other Non-Current Assets surged 11585.0% in 2022 and declined 25.03% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.2 million in 2022, then retreated by 14.33% to $1.9 million in 2023, then retreated by 25.03% to $1.4 million in 2024, then advanced by 29.66% to $1.8 million in 2025, then slipped by 7.33% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $2.0 million in Q3 2025.